Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | UTL | SRE |
|---|---|---|
| Price | $51.77 | $79.69 |
| Change today | ▲ 1.15% | ▼ 0.35% |
| Market cap | $944.11M | $52.11B |
| Return, 3 months | -0.9% | -15.1% |
| Return, year to date | +9.9% | -7.7% |
| Return, 1 year | +11.8% | -12.1% |
| P/E (TTM) | 16.5 | 23.0 |
| P/B | 1.5 | 1.6 |
| P/E percentile vs own 5y | 7th | 58th |
| Dividend yield | 3.57% | 3.27% |
| Revenue growth (YoY, latest qtr) | +14.0% | -0.1% |
| Net profit growth (YoY) | +17.5% | +81.5% |
| Gross margin | 40.3% | 49.8% |
| Operating margin | 18.9% | 25.5% |
| Net margin | 9.5% | 16.7% |
| Return on equity | 9.6% | 7.1% |
| Analyst target vs. price | +6.2% | +28.7% |
| Analyst buy share | 0% | 92% |
| RSI (14) | 49 | 46 |
| 30-day volatility | 14.3% | 21.3% |
| Max drawdown, 1 year | -10.8% | -21.7% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
